BIOLYFRA

Website
Consumer,BioTech,Retail,B2B

Company Bio

Founders

LvlUp insightsGenerated from LvlUp’s portfolio data and the company’s own updates
Similar companies

More in the LvlUp portfolio

See all →

Building something ambitious?

LvlUp Ventures backs founders from first check to late stage.

Apply for funding
Luis Iniesta, Myriam Maldonado
Pre-Seed
Europe
Consumer, BioTech, Retail, B2B
2025
Four sales engines with a 70 to 85% gross margin: Direct-to-consumer sales of Bloom Protocol with a refill subscription as the main channel, turning a one-off sale into recurring revenue; A professional channel of Bloom starting from Q3 2027 (aesthetic clinics and pharmacies as prescribers) to reach the audience that digital channel does not; Licensing a portfolio of proprietary ingredients to partner premium brands or professional skincare companies; B2B sales to distributors and technology licensing to cosmetic companies.

BIOLYFRA is a biotech-enabled premium skincare platform. Its patented bioactive delivery technology enables proven bioactives to cross the skin barrier and reach the epidermis, the Bloom serum being the first commercial validation with future expansion into proprietary ingredients and B2B licensing.